Check out our most popular compounded medications! Get Started
Propafenone HCl 1.5 mg/ml Oral Suspension is a compounded medication, uniformly dispersed in a liquid medium for easy administration. It is primarily used in the treatment of conditions such as Atrial Fibrillation, Ventricular Arrhythmia, Supraventricular Tachycardia, Atrial Flutter, and Wolff-Parkinson-White Syndrome.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Propafenone HCl 1.5 mg/ml Oral Suspension is a specially compounded medication designed to treat a range of heart-related conditions. This formulation is a beta-blocker, a type of medication that functions by blocking specific receptors in the heart. This action helps to slow the heart rate and decrease the risk of arrhythmias, irregular heart rhythms that can lead to serious complications.
It can also be used to manage supraventricular tachycardia and as an antiarrhythmic agent for patients diagnosed with Wolff-Parkinson-White Syndrome, a rare heart condition that can cause a rapid heartbeat.
Propafenone HCl 1.5 mg/ml Oral Suspension is a liquid dosage form, where one or more ingredients are uniformly dispersed throughout a liquid medium. This creates a homogeneous mixture that is easy to administer. This liquid form is especially beneficial for individuals who have difficulty swallowing pills, ensuring they receive their necessary medication without discomfort.
It is crucial to take this medication exactly as prescribed by your healthcare provider. Following the directions on the label and taking the medication at the same time each day can help maintain a consistent level of the drug in your system, enhancing its effectiveness.
This will ensure you are fully informed about your treatment and can monitor any changes in your condition.
If you have any questions or concerns about this formulation, please do not hesitate to contact us at Bayview Pharmacy. We are here to provide you with the information and support you need to manage your health effectively.
Propafenone HCl 1.5 mg/ml Oral Suspension is a compounded formulation designed for the treatment of specific arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. It may also be utilized for the management of supraventricular tachycardia and Wolff-Parkinson-White Syndrome. This medication is a liquid dosage form, where the active ingredient is uniformly dispersed throughout a liquid medium, ensuring a homogeneous mixture for administration.
Patients with hepatic impairment, renal impairment, or congestive heart failure should exercise caution when using Propafenone HCl 1.5 mg/ml Oral Suspension. The same caution applies to patients with a history of bradycardia, hypotension, or QT prolongation. Regular monitoring for signs and symptoms of these conditions is recommended while on this medication.
Propafenone HCl 1.5 mg/ml Oral Suspension may interact with other medications. These include but are not limited to anticoagulants, antiarrhythmics, and certain antibiotics. It is crucial for patients to inform their healthcare provider of all medications they are currently taking. This includes over-the-counter medications, vitamins, and herbal supplements to avoid potential drug interactions.
If you have any questions or concerns about Propafenone HCl 1.5 mg/ml Oral Suspension, it is recommended to consult with your healthcare provider for further information and guidance.
Propafenone HCl 1.5 mg/ml Oral Suspension is a compounded formulation of medication primarily used in the treatment of specific heart rhythm disorders, including atrial fibrillation and atrial flutter. The medication functions by obstructing certain electrical signals within the heart that can lead to an irregular heartbeat, thereby aiding in the restoration of a normal heart rhythm.
The administration of Propafenone HCl 1.5 mg/ml Oral Suspension is typically oral, with the usual dosage being once or twice daily. It is crucial to adhere strictly to the dosage prescribed by your healthcare provider, avoiding taking more or less than the directed amount. To minimize the potential for stomach upset, it is recommended to take this medication with food or milk.
Common side effects associated with Propafenone HCl 1.5 mg/ml Oral Suspension may include nausea, vomiting, dizziness, and headache. If you experience any of these side effects, it is important to promptly contact your healthcare provider. For any queries or concerns regarding Propafenone HCl 1.5 mg/ml Oral Suspension, please do not hesitate to reach out to your healthcare provider or pharmacist.
Propafenone HCl 1.5 mg/ml Oral Suspension is a compounded formulation used in the treatment of various arrhythmias. These include atrioventricular nodal reentrant tachycardia (AVNRT), atrioventricular reentrant tachycardia (AVRT), junctional tachycardia, and ventricular tachycardia, including those induced by digitalis toxicity. Additionally, it can be utilized in the management of paroxysmal supraventricular tachycardia (PSVT) and atrial flutter.
It is crucial to understand that Propafenone HCl 1.5 mg/ml Oral Suspension is not recommended for the treatment of ventricular fibrillation or torsades de pointes. Furthermore, it should not be used to treat Wolff-Parkinson-White Syndrome.
Aside from treating these conditions, Propafenone HCl 1.5 mg/ml Oral Suspension is also used prophylactically to prevent the recurrence of atrial fibrillation and flutter. It also plays a role in reducing the risk of stroke in patients diagnosed with atrial fibrillation.
Propafenone HCl 1.5 mg/ml Oral Suspension is available in various strengths and formulations, including tablets, capsules, and oral suspensions. It is essential to adhere to your healthcare provider's instructions when taking this medication. If you have any queries regarding the use of Propafenone HCl 1.5 mg/ml Oral Suspension, it is recommended to consult with your healthcare provider.
Propafenone HCl 1.5 mg/ml Oral Suspension is a liquid medication that contains the active ingredient Propafenone HCl dispersed uniformly throughout a liquid medium. This formulation is designed to provide a homogeneous mixture for administration.
This medication should be taken as directed by your healthcare provider. The suspension should be shaken well before each use to ensure the medication is evenly distributed.
The liquid medium in the suspension serves as a vehicle for the active ingredient. It helps to disperse the medication evenly, ensuring that each dose contains the correct amount of the active ingredient.
A homogeneous mixture means that the active ingredient is evenly distributed throughout the liquid medium. This ensures that each dose you take contains the same amount of medication.
It's important to follow your healthcare provider's instructions regarding this. Some medications can interact with certain foods or drinks, which can affect how the medication works.
If you miss a dose, take it as soon as you remember. If it's close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
If you suspect an overdose, seek medical attention immediately. Overdosing can lead to serious health complications.
No, you should continue taking the medication for the full course of treatment, even if you start to feel better. Stopping the medication early can lead to a return of the infection or condition.
Like all medications, Propafenone HCl 1.5 mg/ml Oral Suspension can cause side effects. These can range from mild to severe and can include nausea, vomiting, dizziness, and more. If you experience any unusual or severe side effects, contact your healthcare provider immediately.
Before taking this medication, inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. They will be able to advise you on the best course of action based on your specific circumstances.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
